The pharmacogenomic assessment of molecular epithelial-mesenchymal transition signatures reveals drug susceptibilities in cancer cell linesAlexander J. Ohnmacht, Michael P. Menden|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1